logo

Cramer's lightning round: Teladoc is worth buying

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Teladoc Health: "I think Teladoc is part of the way to be able to keep costs down in health care and we've been behind it all the way and we're not budging."

Karuna Therapeutics: "Mental health is almost impossible to get right. It's a total spec. I'm not kidding. Everybody who has tried to crack mental health has really, unfortunately, failed."

Cloudflare: "Here's what your nephew should do: Go over some of the stocks that we talk about a lot on the show, like a cloud king. Be in one of those. They have been vetted and vetted and vetted. I would feel so much better if he did that."

Apellis Pharmaceuticals: "I want you to wait."

Pinterest: "We're kind of lukewarm. We had such high hopes and it doesn't have the growth that we'd like. I have to tell you I prefer Twitter to it, I certainly prefer Facebook."

Veeva Systems: "I would buy it right here. It's one of the stocks that I think is just about poised — it's unchanged, it's almot unchanged for the year — to really make a move."

Alibaba: "Oh, the only Chinese stock I'll recommend. Why, because it's kicking butt and I've got to tell you it looks a lot like an American company, except for it's got faster sales than almost any company on earth."

Cloudera: "It's not as bad as it was. If that's enough to make you want to buy their stock, it's fine with me."

VIDEO5:1405:14
Cramer's lightning round: Teladoc is worth buying

Disclosure: Cramer's charitable trust owns shares of Facebook.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com